Global Pharmaceutical Drug Delivery Market
Pharmaceuticals

Pharmaceutical Drug Delivery Market Anticipated to Record Steady Gains, Advancing to $2612.78 Billion by 2030

Uncover key drivers, emerging technologies, and competitive movements shaping the pharmaceutical drug delivery market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Pharmaceutical Drug Delivery Market’s size between 2026 and 2030?

The pharmaceutical drug delivery market has shown substantial expansion in recent years. Its value is anticipated to rise from $1883.27 billion in 2025 to $2007.97 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.6%. The historical growth of this market can be attributed to factors like the increasing occurrence of chronic diseases, developments in pharmaceutical formulations, the expansion of hospital infrastructure, a growing older population, and the widespread use of oral and injectable drug delivery techniques.

The pharmaceutical drug delivery market is anticipated to demonstrate robust expansion over the next few years, with its size projected to attain $2612.78 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.8%. This growth during the forecast period is primarily driven by the emergence of biologics and biosimilars, the integration of digital monitoring devices, innovations within nanocarrier systems, the increasing adoption of home care and remote treatments, and a rising demand for patient-centric therapies. Significant trends expected during this same period include targeted drug delivery systems, nanotechnology-based formulations, wearable drug delivery devices, personalized medicine solutions, and minimally invasive delivery methods.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6962&type=smp

Which Drivers Are Shaping Strategic Decisions In The Pharmaceutical Drug Delivery Market?

The increasing incidence of chronic illnesses is anticipated to drive the expansion of the pharmaceutical drug delivery market in the future. The term “prevalence of chronic diseases” denotes the overall count of existing instances of these long-term conditions within a population at a given moment. Pharmaceutical drug delivery systems aid patients afflicted with chronic diseases by transporting medicinal compounds to targeted areas of the body for the treatment of various ailments. For example, in September 2023, the World Health Organization, a Switzerland-based specialized agency of the United Nations, reported that non-communicable diseases (NCDs), also known as chronic diseases, were responsible for 41 million deaths annually worldwide, accounting for 74% of all fatalities. Among these, cardiovascular diseases led to 17.9 million deaths, cancer to 9.3 million deaths, chronic respiratory diseases to 4.1 million deaths, and diabetes to 2.0 million deaths. Consequently, the rising prevalence of chronic conditions is a key factor propelling the growth of the pharmaceutical drug delivery market.

What Segment Classifications Make Up The Pharmaceutical Drug Delivery Market?

The pharmaceutical drug delivery market covered in this report is segmented –

1) By Route Of Administration: Oral, Ocular, Pulmonary, Nasal, Injectable, Topical, Other Routes

2) By Application: Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Central Nervous System Disorders, Autoimmune Diseases, Other Applications

3) By End-User: Hospitals, Home Care Settings, ASC Or Clinics, Other End Users

Subsegments:

1) By Oral: Tablets, Capsules, Liquids, Powders

2) By Ocular: Eye Drops, Ocular Inserts, Ocular Implants

3) By Pulmonary: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers

4) By Nasal: Nasal Sprays, Nasal Gels, Nasal Powders

5) By Injectable: Intravenous (IV) Injections, Intramuscular (IM) Injections, Subcutaneous (SC) Injections, Biologics And Biosimilars

6) By Topical: Creams, Ointments, Gels, Transdermal Patches

7) By Other Routes: Sublingual, Buccal, Rectal, Intranasal

What Industry Trends Are Transforming The Pharmaceutical Drug Delivery Market?

Companies operating within the pharmaceutical drug delivery market are increasingly employing a strategic partnership strategy. This approach aims to identify novel transport targets and shuttle molecules to improve the delivery of medicines to the brain. Strategic partnerships are defined as a process where companies leverage each other’s strengths and resources to achieve mutual benefits and success. For example, in September 2023, Cordance Medical, a US-based medical equipment manufacturer, entered into a strategic partnership with EXACT Therapeutics to facilitate drug delivery to the brain. This collaboration integrates Cordance Medical’s NeuroAccess platform, which can non-surgically open the blood-brain barrier (BBB), with EXACT Therapeutics’ Acoustic Cluster Therapy (ACT) technology. The primary goal of this partnership is to enhance treatments for brain diseases such as tumors and neurodegenerative disorders by making it easier for medicines to reach the brain. EXACT Therapeutics is a UK-based, clinical-stage biopharmaceutical company.

Which Major Firms Are Strengthening Their Position In The Pharmaceutical Drug Delivery Market?

Major companies operating in the pharmaceutical drug delivery market are 3M Company., AbbVie Inc., Amgen Inc., AstraZeneca plc, Bayer AG, Becton Dickinson And Company, C. H. Boehringer Sohn AG & Co. KG, Boston Scientific Corporation, Bristol-Myers Squibb Company, Consort Medical plc, Eli Lilly and Company, Emergent Biosolutions Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Johnson & Johnson, Kite Pharma Inc., Merck & Co Inc., Nemera France SAS, Novartis AG, Pfizer Inc, Sanofi S. A., SHL Medical AG, Teva Pharmaceuticals Industries Ltd., West Pharmaceutical Services Inc., Aerogen Pharma Limited, AptarGroup Inc., Biocon Ltd., Catalent Inc., Evonik Industries AG, Inovio Pharmaceuticals Inc., Mylan NV, Sensile Medical Inc., Ypsomed Holding AG

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

Which Region Shows The Strongest Potential For Future Expansion In The Pharmaceutical Drug Delivery Market?

North America was the largest region in the pharmaceutical drug delivery market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical drug delivery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Pharmaceutical Drug Delivery Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=6962&type=smp

Browse Through More Reports Similar to the Global Pharmaceutical Drug Delivery Market 2026, By The Business Research Company

Pharmaceutical Drug Delivery Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

Drug Delivery Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Controlled Release Drug Delivery Market Report 2026

https://www.thebusinessresearchcompany.com/report/controlled-release-drug-delivery-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model